← All Sponsors
SPONSOR

SpectraCure AB

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Recurrent Prostate Cancer
NCT03067051 Phase 1, Phase 2
Recruiting

Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

Recurrent Prostate Cancer
United States, Canada, Sweden View Trial →